Showing results (71-80 of 91) with videos related to
Sort By:
Pageof 10
Journal of Biomolecular Screening|November 2, 2001
The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approachE Delaporte, D E Slaughter, M A Egan, et al.Journal of Appalachian Health|June 30, 2022
Access to Autism Spectrum Disorder Services for Rural Appalachian CitizensAngela Scarpa, Laura S Jensen, Denis Gracanin, et al.BMC Health Services Research|April 26, 2023
Improving measurement-based care implementation in adult ambulatory psychiatry: a virtual focus group interview with multidisciplinary healthcare professionalsHayoung Ko, Alyssa J Gatto, Sydney B Jones, et al.Journal of Patient-Reported Outcomes|November 21, 2024
Assessing the impact of COVID-19 on outpatient psychiatric population well-being and symptomology utilizing COVID-19 Events Checklist (CEC) and Measurement Based CareSydney B Jones, Hayoung Ko, Alyssa J Gatto, et al.Implementation Research and Practice|June 19, 2026
Assessing the Implementation of a Novel Digital Measurement-Based Care Training in Behavioral Health Using the PRISM FrameworkAlyssa J Gatto, Hayoung Ko, Virginia C O'Brien, et al.CNS Drug Reviews|June 5, 2004
TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effectsGregory J Gatto, G Andrees Bohme, William S Caldwell, et al.Journal of Pharmaceutical and Biomedical Analysis|December 29, 2000
High-throughput simultaneous determination of the HIV protease inhibitors indinavir and L-756423 in human plasma using semi-automated 96-well solid phase extraction and LC-MS/MSM J Rose, S A Merschman, R Eisenhandler, et al.Journal of Medicinal Chemistry|October 26, 2021
Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-RafJaclyn R Patterson, Alan P Graves, Patrick Stoy, et al.Biochemical Pharmacology|June 2, 2009
TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophreniaT A Hauser, A Kucinski, K G Jordan, et al.Psychiatric Services (Washington, D.C.)|June 12, 2024
Use of Patient-Reported Outcome Measures to Assess the Effectiveness of Hybrid Psychiatric VisitsVirginia C O'Brien, Anita S Kablinger, Hayoung Ko, et al.Pageof 10